Literature DB >> 21767767

Management of itch in atopic dermatitis.

Judith Hong1, Joerg Buddenkotte, Timothy G Berger, Martin Steinhoff.   

Abstract

Atopic dermatitis is a common, pruritic, inflammatory skin disorder. Chronic, localized, or even generalized pruritus is the diagnostic hallmark of atopic dermatitis, and its management remains a challenge for physicians. The threshold for itch and alloknesis is markedly reduced in these patients, and infections can promote exacerbation and thereby increase the itch. Modern management consists of anti-inflammatory, occasionally antiseptic, as well as antipruritic therapies to address the epidermal barrier as well as immunomodulation or infection. Mild forms of atopic dermatitis may be controlled with topical therapies, but moderate-to-severe forms often require a combination of systemic treatments consisting of antipruritic and immunosuppressive drugs, phototherapy, and topical compounds. In addition, patient education and a therapeutic regimen to help the patient cope with the itch and eczema are important adjuvant strategies for optimized long-term management. This review highlights various topical, systemic, and complementary and alternative therapies, as well as provide a therapeutic ladder for optimized long-term control of itch in atopic dermatitis.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21767767      PMCID: PMC3704137          DOI: 10.1016/j.sder.2011.05.002

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  258 in total

1.  Narrow-band ultraviolet B and broad-band ultraviolet A phototherapy in adult atopic eczema: a randomised controlled trial.

Authors:  N J Reynolds; V Franklin; J C Gray; B L Diffey; P M Farr
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

2.  Efficacy of traditional Chinese herbal therapy in adult atopic dermatitis.

Authors:  M P Sheehan; M H Rustin; D J Atherton; C Buckley; D W Harris; J Brostoff; L Ostlere; A Dawson; D J Harris
Journal:  Lancet       Date:  1992-07-04       Impact factor: 79.321

3.  Cannabinoid agonists attenuate capsaicin-induced responses in human skin.

Authors:  Roman Rukwied; Allan Watkinson; Francis McGlone; Melita Dvorak
Journal:  Pain       Date:  2003-04       Impact factor: 6.961

4.  Hypnotherapy as a treatment for atopic dermatitis in adults and children.

Authors:  A C Stewart; S E Thomas
Journal:  Br J Dermatol       Date:  1995-05       Impact factor: 9.302

Review 5.  Novel aspects in cutaneous biology of acetylcholine synthesis and acetylcholine receptors.

Authors:  Hjalmar Kurzen; Karin U Schallreuter
Journal:  Exp Dermatol       Date:  2004       Impact factor: 3.960

Review 6.  Chronic pruritus--pathogenesis, clinical aspects and treatment.

Authors:  M Metz; S Ständer
Journal:  J Eur Acad Dermatol Venereol       Date:  2010-09-15       Impact factor: 6.166

7.  Treatment of pruritus with topically applied opiate receptor antagonist.

Authors:  Paul L Bigliardi; Holger Stammer; Gerhard Jost; Theo Rufli; Stanislaw Büchner; Mei Bigliardi-Qi
Journal:  J Am Acad Dermatol       Date:  2007-02-22       Impact factor: 11.527

Review 8.  Proactive therapy of atopic eczema--an evidence-based concept with a behavioral background.

Authors:  Andreas Wollenberg; Reiner Frank; Julia Kroth; Thomas Ruzicka
Journal:  J Dtsch Dermatol Ges       Date:  2008-08-07       Impact factor: 5.584

Review 9.  Written action plans: potential for improving outcomes in children with atopic dermatitis.

Authors:  Sarah S Chisolm; Sarah L Taylor; Rajesh Balkrishnan; Steven R Feldman
Journal:  J Am Acad Dermatol       Date:  2008-05-29       Impact factor: 11.527

10.  Inhibitory effect of lidocaine on pain and itch using formalin-induced nociception and 5'-guanidinonaltrindole-induced scratching models in mice: behavioral and neuroanatomical evidence.

Authors:  Saadet Inan; Nae J Dun; Alan Cowan
Journal:  Eur J Pharmacol       Date:  2009-06-21       Impact factor: 4.432

View more
  33 in total

1.  Is integrative medicine the next new frontier in medicine?

Authors:  Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2013-06       Impact factor: 8.667

Review 2.  The role of the skin microbiome in atopic dermatitis.

Authors:  Michael R Williams; Richard L Gallo
Journal:  Curr Allergy Asthma Rep       Date:  2015-11       Impact factor: 4.806

Review 3.  Mediators of Chronic Pruritus in Atopic Dermatitis: Getting the Itch Out?

Authors:  Nicholas K Mollanazar; Peter K Smith; Gil Yosipovitch
Journal:  Clin Rev Allergy Immunol       Date:  2016-12       Impact factor: 8.667

Review 4.  MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.

Authors:  Jessica Oliboni Scapineli; Lucieli Ceolin; Márcia Khaled Puñales; José Miguel Dora; Ana Luiza Maia
Journal:  Fam Cancer       Date:  2016-10       Impact factor: 2.375

5.  PAR2 Mediates Itch via TRPV3 Signaling in Keratinocytes.

Authors:  Jiahui Zhao; Admire Munanairi; Xian-Yu Liu; Jie Zhang; Linghan Hu; Meiqin Hu; Dingfang Bu; Lingling Liu; Zhiqiang Xie; Brian S Kim; Yong Yang; Zhou-Feng Chen
Journal:  J Invest Dermatol       Date:  2020-01-29       Impact factor: 8.551

6.  The aryl hydrocarbon receptor AhR links atopic dermatitis and air pollution via induction of the neurotrophic factor artemin.

Authors:  Takanori Hidaka; Eisaku Ogawa; Eri H Kobayashi; Takafumi Suzuki; Ryo Funayama; Takeshi Nagashima; Taku Fujimura; Setsuya Aiba; Keiko Nakayama; Ryuhei Okuyama; Masayuki Yamamoto
Journal:  Nat Immunol       Date:  2016-11-21       Impact factor: 25.606

7.  IL-33: a novel danger signal system in atopic dermatitis.

Authors:  Ferda Cevikbas; Martin Steinhoff
Journal:  J Invest Dermatol       Date:  2012-05       Impact factor: 8.551

8.  Synergistic antipruritic effects of gamma aminobutyric acid A and B agonists in a mouse model of atopic dermatitis.

Authors:  Ferda Cevikbas; Joao M Braz; Xidao Wang; Carlos Solorzano; Mathias Sulk; Timo Buhl; Martin Steinhoff; Allan I Basbaum
Journal:  J Allergy Clin Immunol       Date:  2017-02-21       Impact factor: 10.793

9.  The ion channel TRPA1 is required for chronic itch.

Authors:  Sarah R Wilson; Aislyn M Nelson; Lyn Batia; Takeshi Morita; Daniel Estandian; David M Owens; Ellen A Lumpkin; Diana M Bautista
Journal:  J Neurosci       Date:  2013-05-29       Impact factor: 6.167

10.  Advanced aging skin and itch: addressing an unmet need.

Authors:  Lilit Garibyan; Albert S Chiou; Sarina B Elmariah
Journal:  Dermatol Ther       Date:  2013 Mar-Apr       Impact factor: 2.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.